These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 27045133)

  • 1. Heterozygous Familial Hypercholesterolemia.
    Onorato A; Sturm AC
    Circulation; 2016 Apr; 133(14):e587-9. PubMed ID: 27045133
    [No Abstract]   [Full Text] [Related]  

  • 2. Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Daniels SR; Gidding SS; de Ferranti SD;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S30-7. PubMed ID: 21600527
    [No Abstract]   [Full Text] [Related]  

  • 3. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.
    van der Graaf A; Hutten BA; Kastelein JJ; Vissers MN
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):345-51. PubMed ID: 16716095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial hypercholesterolemia: current treatment and advances in management.
    Huijgen R; Vissers MN; Defesche JC; Lansberg PJ; Kastelein JJ; Hutten BA
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):567-81. PubMed ID: 18402545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial hypercholesterolemia--we must act boldly.
    Moodie D
    Congenit Heart Dis; 2014; 9(4):273-4. PubMed ID: 25099345
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening.
    Kjærgaard KA; Christiansen MK; Schmidt M; Olsen MS; Jensen HK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28652386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of high total cholesterol with coronary heart disease mortality differs among subject populations--familial hypercholesterolemia as a key concept.
    Okuyama H; Ichikawa Y; Sun Y; Hamazaki T; Lands WE
    World Rev Nutr Diet; 2007; 96():19-36. PubMed ID: 17167278
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of children with heterozygous familial hypercholesterolemia.
    Reiner Ž; Sahebkar A
    Int J Cardiol; 2020 Apr; 304():177-178. PubMed ID: 31735366
    [No Abstract]   [Full Text] [Related]  

  • 9. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholesterol and family history: when genetics matters.
    Vengoechea J; McKelvey KD
    J Ark Med Soc; 2015 Feb; 111(9):184-6. PubMed ID: 25993767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The Netherlands.
    Wonderling D; Umans-Eckenhausen MA; Marks D; Defesche JC; Kastelein JJ; Thorogood M
    Semin Vasc Med; 2004 Feb; 4(1):97-104. PubMed ID: 15199439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP
    Int Angiol; 2011 Jun; 30(3):295; author reply 296. PubMed ID: 21617615
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol.
    Chaves FJ; Real JT; García-García AB; Civera M; Armengod ME; Ascaso JF; Carmena R
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4926-32. PubMed ID: 11600564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia.
    Miltiadous G; Saougos V; Cariolou M; Elisaf MS
    Ann Clin Lab Sci; 2006; 36(3):353-5. PubMed ID: 16951279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A familial hypercholesterolemia week in Kyrgyzstan: The joint scientific and practical symposium with the European Atherosclerosis Society (EAS), the International Atherosclerosis Society (IAS) and the Kyrgyz Society of Cardiology (KSC).
    Lunegova OS; Mirrakhimov EM
    Atherosclerosis; 2019 Feb; 281():198-199. PubMed ID: 30545666
    [No Abstract]   [Full Text] [Related]  

  • 16. Arterial abnormalities in children with familial hypercholesterolaemia.
    Raitakari OT
    Lancet; 2004 Jan; 363(9406):342-3. PubMed ID: 15070559
    [No Abstract]   [Full Text] [Related]  

  • 17. Familial hypercholesterolaemia: A guide for general practice.
    Brett T; Arnold-Reed D
    Aust J Gen Pract; 2019 Sep; 48(9):650-652. PubMed ID: 31476827
    [No Abstract]   [Full Text] [Related]  

  • 18. Pediatric implications of heterozygous familial hypercholesterolemia. Screening and dietary treatment.
    Kwiterovich PO
    Arteriosclerosis; 1989; 9(1 Suppl):I111-20. PubMed ID: 2563219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and Management of Individuals With Heterozygous Familial Hypercholesterolemia: Too Late and Too Little.
    Hovingh GK; Kastelein JJ
    Circulation; 2016 Sep; 134(10):710-2. PubMed ID: 27601557
    [No Abstract]   [Full Text] [Related]  

  • 20. Landmark position paper on paediatric familial hypercholesterolaemia from the EAS Consensus Panel.
    Stock J
    Atherosclerosis; 2015 Sep; 242(1):277-80. PubMed ID: 26232168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.